Increased Frequency of Dysfunctional Siglec-7−CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is a progressive disorder that can develop into liver fibrosis and hepatocellular carcinoma. Natural killer (NK) cells have been shown to protect against liver fibrosis and tumorigenesis, suggesting that they may also play a role in the pathogenesis of NAFLD. Sialic acid-binding immunoglobulin-like lectins (Siglecs) are a family of inhibitory and activating receptors expressed by many cell types, including NK cells. Here, we investigated the phenotypic profiles of peripheral blood and intrahepatic NK cells, including expression of Siglecs and immune checkpoint molecules, and their association with NK cell function in patients with NAFLD. Immune cells in the peripheral blood of 42 patients with biopsy-proven NAFLD and 13 healthy volunteers (HVs) were identified by mass cytometry. The function of various NK cell subpopulations was assessed by flow cytometric detection of intracellular IFN-γ and CD107a/LAMP-1, a degranulation marker, after in vitro stimulation. We found that peripheral blood from NAFLD patients, regardless of fibrosis stage, contained significantly fewer total CD56+ NK cell and CD56dim NK cell populations compared with HVs, and the CD56dim cells from NAFLD patients were functionally impaired. Among the Siglecs examined, NK cells predominantly expressed Siglec-7 and Siglec-9, and both the expression levels of Siglec-7 and Siglec-9 on NK cells and the frequencies of Siglec-7+CD56dim NK cells were reduced in NAFLD patients. Notably, Siglec-7 levels on CD56dim NK cells were inversely correlated with PD-1, CD57, and ILT2 levels and positively correlated with NKp30 and NKp46 levels. Further subtyping of NK cells identified a highly dysfunctional Siglec-7−CD57+PD-1+CD56dim NK cell subset that was increased in patients with NAFLD, even those with mild liver fibrosis. Intrahepatic NK cells from NAFLD patients expressed elevated levels of NKG2D and CD69, suggesting a more activated phenotype than normal liver NK cells. These data identify a close association between NK cell function and expression of Siglec-7, CD57, and PD-1 that could potentially be therapeutically targeted in NAFLD.

[1]  A. Lohse,et al.  Characterization of the immune cell landscape of patients with NAFLD , 2020, PloS one.

[2]  G. Mellgren,et al.  Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease , 2019, Front. Immunol..

[3]  Clara Di Vito,et al.  Hepatic Natural Killer Cells: Organ-Specific Sentinels of Liver Immune Homeostasis and Physiopathology , 2019, Front. Immunol..

[4]  M. Shong,et al.  T-cell senescence contributes to abnormal glucose homeostasis in humans and mice , 2019, Cell Death & Disease.

[5]  Lifen Gao,et al.  Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication , 2018, Front. Immunol..

[6]  Leo Swadling,et al.  IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction , 2018, Front. Immunol..

[7]  D. Margolis,et al.  Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo , 2018, Journal of Virology.

[8]  E. Sahai,et al.  NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control , 2018, Cell.

[9]  Abigail K Kimball,et al.  A Beginner’s Guide to Analyzing and Visualizing Mass Cytometry Data , 2018, The Journal of Immunology.

[10]  Vincent Wai-Sun Wong,et al.  New trends on obesity and NAFLD in Asia. , 2017, Journal of hepatology.

[11]  H. Kielstein,et al.  Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans , 2017, Immunologic Research.

[12]  Y. Cheng,et al.  Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers , 2017, Oncogene.

[13]  C. Mantzoros,et al.  Adipose tissue, obesity and non-alcoholic fatty liver disease. , 2017, Minerva endocrinologica.

[14]  C. Dumontet,et al.  Alteration of Natural Killer cell phenotype and function in obese individuals. , 2017, Clinical immunology.

[15]  Liang Chen,et al.  The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease , 2017, Oncotarget.

[16]  Sun-Hee Kim,et al.  Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity. , 2017, Human immunology.

[17]  H. Lee,et al.  Association between non-alcoholic fatty liver disease and cancer incidence rate. , 2017, Journal of hepatology.

[18]  D. Olive,et al.  PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma , 2016, Oncotarget.

[19]  H. Ljunggren,et al.  Emerging insights into natural killer cells in human peripheral tissues , 2016, Nature Reviews Immunology.

[20]  E. Wisse,et al.  Liver natural killer cells: subsets and roles in liver immunity , 2015, Cellular and Molecular Immunology.

[21]  N. Leitinger,et al.  NKp46+ natural killer cells attenuate metabolism‐induced hepatic fibrosis by regulating macrophage activation in mice , 2015, Hepatology.

[22]  G. Ferraioli,et al.  Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection , 2015, Gut.

[23]  E. Bjornsson,et al.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. , 2015, Gastroenterology.

[24]  G. Cooke,et al.  The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa , 2015, Gut.

[25]  Cheng-song Sun,et al.  Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy , 2015, Acta Pharmacologica Sinica.

[26]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  L. Hübner,et al.  Altered NK cell function in obese healthy humans , 2015, BMC Obesity.

[28]  J. Boscarino,et al.  The validity of serum markers for fibrosis staging in chronic hepatitis B and C , 2014, Journal of viral hepatitis.

[29]  H. Moch,et al.  Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. , 2014, Cancer cell.

[30]  P. Romero,et al.  Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. , 2014, The Journal of clinical investigation.

[31]  Stephen M. Canham,et al.  Glycocalyx Engineering Reveals a Siglec-Based Mechanism for NK Cell Immunoevasion , 2013, Nature chemical biology.

[32]  E. Riley,et al.  Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease , 2013, Front. Immunol..

[33]  Z. Tian,et al.  Natural killer cells in liver disease , 2013, Hepatology.

[34]  Sumati Rajagopalan,et al.  Controlling natural killer cell responses: integration of signals for activation and inhibition. , 2013, Annual review of immunology.

[35]  J. Lord,et al.  Reduced release and binding of perforin at the immunological synapse underlies the age‐related decline in natural killer cell cytotoxicity , 2012, Aging cell.

[36]  S. Ludovisi,et al.  Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection , 2012, Hepatology.

[37]  K. Cusi,et al.  Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[38]  K. Cusi,et al.  The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[39]  P. Crocker,et al.  CD33‐related siglecs as potential modulators of inflammatory responses , 2012, Annals of the New York Academy of Sciences.

[40]  I. Ng,et al.  Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma , 2011, Gut.

[41]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[42]  C. Lutz,et al.  Human NK Cells Proliferate and Die In Vivo More Rapidly than T Cells in Healthy Young and Elderly Adults , 2011, The Journal of Immunology.

[43]  H. Pircher,et al.  CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. , 2010, Blood.

[44]  M. Caligiuri,et al.  The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. , 2010, Blood.

[45]  A. Órfão,et al.  Chronic alcohol consumption is associated with an increased cytotoxic profile of circulating lymphocytes that may be related with the development of liver injury. , 2010, Alcoholism, clinical and experimental research.

[46]  L. Lynch,et al.  Natural Killer Cells in Obesity: Impaired Function and Increased Susceptibility to the Effects of Cigarette Smoke , 2010, PloS one.

[47]  D. Focosi,et al.  CD57+ T lymphocytes and functional immune deficiency , 2010, Journal of leukocyte biology.

[48]  A. Moretta,et al.  The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. , 2009, Blood.

[49]  G. Michelone,et al.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. , 2009, Gastroenterology.

[50]  P. Tien,et al.  Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. , 2008, Clinical immunology.

[51]  B. Bochner,et al.  Basic and Clinical Immunology of Siglecs , 2008, Annals of the New York Academy of Sciences.

[52]  Ajit Varki,et al.  Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins , 2007, Nature.

[53]  Ajit Varki,et al.  Siglecs and their roles in the immune system , 2007, Nature Reviews Immunology.

[54]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[55]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[56]  A. Varki,et al.  Siglecs--the major subfamily of I-type lectins. , 2006, Glycobiology.

[57]  C. Lutz,et al.  Reciprocal age related change in natural killer cell receptors for MHC class I , 2005, Mechanisms of Ageing and Development.

[58]  R. Vaughan,et al.  Isolation, purification and flow cytometric analysis of human intrahepatic lymphocytes using an improved technique , 2005, Laboratory Investigation.

[59]  D. Doherty,et al.  Hepatic interleuklin 15 (IL‐15) expression: implications for local NK/NKT cell homeostasis and development , 2004, Clinical and experimental immunology.

[60]  R. Groszmann,et al.  American association for the study of liver diseases , 1992 .

[61]  Mark J. Smyth,et al.  Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.

[62]  T. Imperiale,et al.  Clinical utility of the AST/ALT ratio in chronic hepatitis C , 2001, American Journal of Gastroenterology.

[63]  L. Lanier,et al.  Immune inhibitory receptors. , 2000, Science.

[64]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[65]  C. Caruso,et al.  Granulocyte and natural killer activity in the elderly , 1999, Mechanisms of Ageing and Development.

[66]  D. Sgroi,et al.  Siglecs: a family of sialic-acid binding lectins. , 1998, Glycobiology.